@article{cb774ed680a04ec88d1d9399551a73b1,
title = "Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients",
abstract = "The efficacy and safety of prolonging prophylaxis for venous thromboembolism in medically ill patients beyond hospital discharge remain uncertain. We hypothesized that extended prophylaxis with apixaban would be safe and more effective than short-term prophylaxis with enoxaparin.",
keywords = "Acute Disease, Adult, Aged, Aged, 80 and over, Anticoagulants, Double-Blind Method, Drug Administration Schedule, Enoxaparin, Female, Heart Failure, Hemorrhage, Hospitalization, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Pulmonary Embolism, Pyrazoles, Pyridones, Respiratory Insufficiency, Risk Factors, Treatment Outcome, Venous Thromboembolism",
author = "Goldhaber, {Samuel Z} and Alain Leizorovicz and Kakkar, {Ajay K} and Haas, {Sylvia K} and Geno Merli and Knabb, {Robert M} and Weitz, {Jeffrey I} and {ADOPT Trial Investigators (Christian Tobias Torp-Pedersen, members)} and Torp-Pedersen, {Christian Tobias}",
year = "2011",
month = dec,
day = "8",
doi = "10.1056/NEJMoa1110899",
language = "English",
volume = "365",
pages = "2167--77",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "23",
}